CTT Pharmaceutical Holdings, Inc. balance sheet CTTH

Annual Quarterly

As of Jun 30, 2026, CTT Pharmaceutical Holdings, Inc. had total assets of $67,434. Stockholders' equity was $26,043. Cash and investments were $31. The current ratio, current assets divided by current liabilities, was 0.00.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q2 FY2026 Jun 30, 2026	Q3 FY2015 Sep 30, 2015	Q2 FY2015 Jun 30, 2015	Q1 FY2015 Mar 31, 2015	Q4 FY2014 Dec 31, 2014	Q3 FY2014 Sep 30, 2014	Q2 FY2014 Jun 30, 2014	Q1 FY2014 Mar 31, 2014
Assets
Cash	0	0 -74.4%	0 +1155.7%	0 +1516.0%	0	0	0 -53.7%	0 -76.1%
Cash and investments	0	0 -74.4%	0 +1155.7%	0 +1516.0%	0	0	0 -53.7%	0 -76.1%
Receivables	—	0	0	0	0	—	—	—
Total current assets	0	1	1	1	1 +16690.4%	—	—	—
Total assets	0	1 +605.2%	1 +420.0%	1 +8140.0%	2	0 +1787.8%	0 +1478.4%	0 -56.1%
Liabilities and equity
Total current liabilities	0	—	—	—	—	—	—	—
Total liabilities	—	0 +47.6%	0 +10.1%	0 -24.4%	0 +478.0%	0 -74.9%	0 -71.1%	0 -39.6%
Stockholders' equity	0	1 +11905.2%	1 +1100.3%	1 +559.6%	1 +5191.3%	0 +101.3%	0 +118.0%	-0 +38.0%
Ratios
Current ratio	0.00x	—	—	—	—	—	—	—
Return on equity	—	-226.28%	-133.34%	-83.46%	-45.02%	-831.65%	96.61%	—
Return on assets	—	-181.14%	-115.72%	-71.01%	-40.43%	-39.11%	36.32%	115.37%
Book value per share	0.00	0.03	0.05	0.06	0.08	0.00	0.00	-0.03

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: CTTH (OTC)
Fiscal year ends: December 31
Incorporated in: FL
Headquarters: Tampa, FL
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 1035422
Former names: Mindesta Inc. (until Jul 21, 2015); INDUSTRIAL MINERALS INC (until Jul 18, 2011); PNW CAPITAL INC (until May 21, 2002); WINCHESTER MINING CORP (until May 26, 2000)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.